CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
68 hedge funds and large institutions have $159M invested in Concert Pharmaceuticals, Inc. in 2015 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 24 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
26% more funds holding
Funds holding: 54 → 68 (+14)
Holders
68
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10M | |
| 2 | +$7.27M | |
| 3 | +$3.78M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.41M |
| 5 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$2.23M |
Top Sellers
| 1 | -$1.65M | |
| 2 | -$1.52M | |
| 3 | -$1.35M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$607K |
| 5 |
BG
BlackRock Group
London,
United Kingdom
|
-$307K |